IV. Considerations to Date:
Federal Agencies
1. Drug Cabinet Council meeting 12/12, issue on the agenda
2. Funding for medical research literature review
3. Lead government’s message development
4. Model State Drug Law Alliance monitoring and development of
laws with national strategy
5. Assist in developing medical information clearing house
6. Determine what impact the initiatives have on federal funding to
states which do not cooperate in a national drug strategy